290 related articles for article (PubMed ID: 25467845)
1. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V
Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
[TBL] [Abstract][Full Text] [Related]
3. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
[TBL] [Abstract][Full Text] [Related]
4. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
Kon V; Yang H; Fazio S
Arch Med Res; 2015 Jul; 46(5):379-91. PubMed ID: 26009251
[TBL] [Abstract][Full Text] [Related]
5. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
Rastogi A
Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
[TBL] [Abstract][Full Text] [Related]
6. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
Shroff R; Speer T; Colin S; Charakida M; Zewinger S; Staels B; Chinetti-Gbaguidi G; Hettrich I; Rohrer L; O'Neill F; McLoughlin E; Long D; Shanahan CM; Landmesser U; Fliser D; Deanfield JE
J Am Soc Nephrol; 2014 Nov; 25(11):2658-68. PubMed ID: 24854267
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.
Mao JY; Sun JT; Yang K; Shen WF; Lu L; Zhang RY; Tong X; Liu Y
J Diabetes Complications; 2017 Oct; 31(10):1538-1543. PubMed ID: 28760652
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V
J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484
[TBL] [Abstract][Full Text] [Related]
9. Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells.
Stannard AK; Khan S; Graham A; Owen JS; Allen SP
Atherosclerosis; 2001 Jan; 154(1):31-8. PubMed ID: 11137080
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.
Cockerill GW; Rye KA; Gamble JR; Vadas MA; Barter PJ
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1987-94. PubMed ID: 7583580
[TBL] [Abstract][Full Text] [Related]
11. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.
Rysz J; Gluba-Brzózka A; Rysz-Górzyńska M; Franczyk B
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963445
[TBL] [Abstract][Full Text] [Related]
12. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
Ganda A; Yvan-Charvet L; Zhang Y; Lai EJ; Regunathan-Shenk R; Hussain FN; Avasare R; Chakraborty B; Febus AJ; Vernocchi L; Lantigua R; Wang Y; Shi X; Hsieh J; Murphy AJ; Wang N; Bijl N; Gordon KM; de Miguel MH; Singer JR; Hogan J; Cremers S; Magnusson M; Melander O; Gerszten RE; Tall AR
J Mol Cell Cardiol; 2017 Nov; 112():114-122. PubMed ID: 28478047
[TBL] [Abstract][Full Text] [Related]
13. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
Marsche G; Heine GH; Stadler JT; Holzer M
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
[TBL] [Abstract][Full Text] [Related]
14. IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD.
Hung AM; Tsuchida Y; Nowak KL; Sarkar S; Chonchol M; Whitfield V; Salas N; Dikalova A; Yancey PG; Huang J; Linton MF; Ikizler TA; Kon V
Clin J Am Soc Nephrol; 2019 May; 14(5):702-711. PubMed ID: 31015261
[TBL] [Abstract][Full Text] [Related]
15. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
16. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.
Cockerill GW; Huehns TY; Weerasinghe A; Stocker C; Lerch PG; Miller NE; Haskard DO
Circulation; 2001 Jan; 103(1):108-12. PubMed ID: 11136694
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic kidney disease on macrophage cholesterol efflux.
Meier SM; Wultsch A; Hollaus M; Ammann M; Pemberger E; Liebscher F; Lambers B; Fruhwürth S; Stojakovic T; Scharnagl H; Schmidt A; Springer A; Becker J; Aufricht C; Handisurya A; Kapeller S; Röhrl C; Stangl H; Strobl W
Life Sci; 2015 Sep; 136():1-6. PubMed ID: 26135622
[TBL] [Abstract][Full Text] [Related]
19. High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport.
Anderson JL; Gautier T; Nijstad N; Tölle M; Schuchardt M; van der Giet M; Tietge UJ
Sci Rep; 2017 Feb; 7():41481. PubMed ID: 28148911
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality.
Muñoz-Vega M; Massó F; Páez A; Carreón-Torres E; Cabrera-Fuentes HA; Fragoso JM; Pérez-Hernández N; Martinez LO; Najib S; Vargas-Alarcón G; Pérez-Méndez Ó
Lipids Health Dis; 2018 Mar; 17(1):44. PubMed ID: 29523150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
